Autism spectrum disorder (ASD) is very heterogeneous and multiple subtypes and etiologies likely exist. The maternal immune system has been implicated in the pathogenesis of some forms of ASD. Previous studies have identified the presence of specific maternal IgG autoant ibodies with reactivity to fetal brain proteins at 37 and 73 kDa in up to 12% of mothers of children with ASD. The current study evaluates the presence of these autoantibodies in an independent cohort of mothers of 181 preschool-aged male children (131 ASD, 50 typically developing (TD) controls). We also investigated whether ASD children born to mothers with these autism-specific maternal IgG autoantibodies exhibit a distinct neural phenotype by evaluating total brain volume using structural magnetic resonance imaging (MRI). Of the 131 ASD children, 10 (7.6%) were born to mothers with the 37/73 kDa IgG autoantibodies (ASD-IgG). The mothers of the remaining ASD children and all TD controls were negat ive for these paired autoantibodies. While both ASD groups exhibited abnormal brain enlargement that is commonly observed in this age range, the ASD-IgG group exhibited a more extreme 12.1% abnormal brain enlargement relative to the TD controls. In contrast, the remaining ASD children exhibited a smaller 4.4% abnormal brain enlargement relative to TD controls. Lobar and tissue type analyses revealed that the frontal lobe is selectively enlarge d in the ASD-IgG group and that both gray and white matter are similarly affected. These results suggest that maternal autoantibodies associated with autism spectrum disorder may impact brain development leading to abnormal enlargement.
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Introduction
Autism spectrum disorder (ASD) is a lifelong neurodevelop mental disorder characterized by core deficits in social interaction, communicati on, and restricted interests and repetitive behaviors (APA, 1994 ) . ASD is a heterogeneous disorder with varied behavioral presenta tions, as well as multiple co-morbid disorders such as developmen tal delay, epilepsy, ADHD, and anxiety (Geschwind and Levitt, 2007; Amaral et al., 2008 ) . It is likely that multiple etiologies exist, and immune dysfunction has been implicated in the pathogenes is of a subset of children with ASD.
There is a growing body of evidence suggesting that the maternal immune response may play a role in the etiology of ASD (Zimmerman et al., 2007; Singer et al., 2009 ) . During gestation, the fetal immune system is immature and the fetus relies on maternal IgG autoantib odies to defend against pathogens (Garty et al., 1994 ) . Although this is normally protective, some maternal IgG autoantibodies react with fetal brain tissue and may impact neural development (Braunschwe ig and Van de Water, 2012 ) . Van de Water and colleagues have identified an association between a specific banding pattern of maternal IgG autoantibodies and the presence of ASD in the offspring (Braunschweig et al., 2008; Braunschwe ig et al., 2012 ) . Maternal IgG reactivity to 37 kDa and 73 kDa proteins in fetal brain tissue was observed in 7-12% of mothers of children with ASD, but not in any mothers of typically developing controls or children with other developmental delays.
While these observati onal studies highlight the potential risk associate d with these specific maternal autoantibod ies, the pathologic significance of these autoantibodies remains to be determined. Do these autoantibodies impact neurodevelop ment in the fetus? In the current study, we investiga ted whether a specific neural phenotyp e in ASD males is associated with the presence of the 37/73 kDa maternal IgG autoantibodies. Participants were enrolled
